granted
on 28 Nov 2022
Last Applicant/ Owned by
430 E. 29th Street, 14th Floor
New York
NY
10016
Serial Number
90571068 filed on 10th Mar 2021
Registration Number
N/A
Correspondent Address
Xiomara Triana
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
TELSY RINK Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromeRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies
No 90571068
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 30th Nov 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 28th Nov 2022 | SOU EXTENSION 1 GRANTED |
| 28th Nov 2022 | SOU EXTENSION 1 FILED |
| 28th Nov 2022 | TEAS EXTENSION RECEIVED |
| 07th Jun 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 12th Apr 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Apr 2022 | PUBLISHED FOR OPPOSITION |
| 23rd Mar 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 08th Mar 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 08th Mar 2022 | EXAMINERS AMENDMENT E-MAILED |
